Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....

Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...

From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes...

Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information...

Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs...

Pioneer in precision prevention explains the shift to precision medicine in primary care, and the work of Sanford Imagenetics in creating precision medicine modules for physicians...

Walking the fine line between not being the biggest risk taker and not being the last adopter, hospitals that offer genetic testing can expect their market share to increase and their payer mix to improve, according to LSUHSC’s Miele...

Lori Anderson of XIFIN to share views on the current state of informatics in precision medicine as well as challenges and future trends for this field...

Michael Astion, MD, PhD, to share how the philosophy of the “two rights” can drive alignment and compromise among payers, providers, and patients...